More

    Sun Pharma to acquire US-based Ocular Technologies

    Must Read

    Electric loco shed Vadodara received award for innovative Push Pull project

    Western Railway’s Electric Loco Shed at Vadodara has added a feather to its cap by securing the...

    Konark Corps organised Mel Milap enroute and medical camp at Jaisalmer

    As part of commemoration of the commencement of Golden Jubilee year of 1971 Indo- Pak War, Konark...

    Covid 19 cases reached 18137 in Vadodara after 110 new cases on Tuesday

    Continue the rise Covid 19 cases in Vadodara reached 18137 after 110 cases registered in last 24...

    Indian drug major Sun Pharmaceutical Industries Ltd has entered into definitive agreements by its wholly owned subsidiary to acquire Ocular Technologies, Sarl (OTS), the company said.

    In a statement issued late Wednesday, Sun Pharma said OTS was a portfolio company of Auven Therapeutics (Auven), an international private equity firm focused on accelerated development of breakthrough therapeutic drugs.

    Sun Pharma will pay Auven $40 million upfront, plus contingent development milestones and sales milestones as well as tiered royalty on sales of Seciera as consideration for this acquisition.

    OTS owns exclusive, worldwide rights to Seciera (cyclosporine A, 0.09 per cent ophthalmic solution).

    Seciera is currently in a Phase-3 confirmatory clinical trial for the treatment of Dry Eye Disease, an inflammatory ocular disease affecting approximately 16 million people in the US alone.

    Seciera is a patented, novel, proprietary formulation of cyclosporine A 0.09 per cent.

    “This potential acquisition signifies continued momentum in enhancing our global branded specialty portfolio,” Dilip Shanghvi, Managing Director, Sun Pharma, was quoted as saying in the statement.

    “Coupled with our existing pipeline consisting of BromSite, DexaSite and Xelpros, this initiative will enable Sun Pharma to significantly expand its ophthalmic presence and reach millions of patients globally,” he said.

    The transaction is subject to approval of the US Federal Trade Commission as required under the Hart-Scott-Rodino Act and other closing conditions and is expected to be completed by end of 2016.

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here

    This site uses Akismet to reduce spam. Learn how your comment data is processed.

    Latest News

    Konark Corps organised Mel Milap enroute and medical camp at Jaisalmer

    As part of commemoration of the commencement of Golden Jubilee year of 1971 Indo- Pak War, Konark...

    Konark Corps organised Mel Milap enroute and medical camp at Jaisalmer

    As part of commemoration of the commencement of Golden Jubilee year of 1971 Indo- Pak War, Konark Corps has undertaken a 1971...

    Covid 19 cases reached 18137 in Vadodara after 110 new cases on Tuesday

    Continue the rise Covid 19 cases in Vadodara reached 18137 after 110 cases registered in last 24 hours. Total 88 patients discharged...

    Chhattisgarh: Naxalites blow up civilian vehicle in Bijapur, 2 injured

    Two persons were injured after Naxalites blew up their vehicle using an improvised explosive device (IED) in Chhattisgarh's Bijapur district on Tuesday,...

    Dabhoi BJP MLA demand law of Love Jihad in Gujarat

    The MLA of Dabhoi has demanded the Chief Minister to implement the law of Love Jihad in Gujarat as the cases of...

    More Articles Like This

    - Advertisement -